Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
277
datasets available to search
ShareScore release 0.9.0
Dataset results
277 results for “Lapatinib”
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
ClinicalTrials.gov study NCT00272987. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT01160211. IPD Sharing: YES. Countries: 29. Publications: 2.
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic S
ClinicalTrials.gov study NCT01808573. IPD Sharing: YES. Countries: 28. Publications: 2.
Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
ClinicalTrials.gov study NCT00709761. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
ClinicalTrials.gov study NCT00263588. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00667251. IPD Sharing: YES. Countries: 21. Publications: 3.
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00820222. IPD Sharing: UNDECIDED. Countries: 14. Publications: 1.
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
ClinicalTrials.gov study NCT00553358. IPD Sharing: YES. Countries: 24. Publications: 10.
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
ClinicalTrials.gov study NCT00490139. IPD Sharing: YES. Countries: 44. Publications: 7.
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
ClinicalTrials.gov study NCT00680901. IPD Sharing: YES. Countries: 23. Publications: 2.
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00073528. IPD Sharing: YES. Countries: 29. Publications: 6.
Lapatinib and Bevacizumab for Metastatic Breast Cancer
ClinicalTrials.gov study NCT00444535. IPD Sharing: YES. Countries: 1. Publications: 1.
Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China
ClinicalTrials.gov study NCT00508274. IPD Sharing: YES. Countries: 2. Publications: 1.
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT00777101. IPD Sharing: Not stated. Countries: 31. Publications: 1.
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
ClinicalTrials.gov study NCT00526669. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer
ClinicalTrials.gov study NCT00356811. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
ClinicalTrials.gov study NCT00524303. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
ClinicalTrials.gov study NCT00390455. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00320385. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
ClinicalTrials.gov study NCT01769508. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.